πŸ“Š This is a profile preview from the Tablestat.com Platform Request a Free Trial Now

Valuation Trading Multiples & Precedent Transactions: Online Pharmacy and Telehealth Companies

Valuation benchmarks for Online Pharmacy and Telehealth Companies. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.

1.1 - Online Pharmacy and Telehealth Companies Market Context & Valuation Drivers

Companies in this group operate online pharmacy platforms that dispense prescription and OTC medications via mail‑order logistics, complemented by health and personal care marketplaces and, in some cases, telemedicine. They monetize through e-commerce product sales, prescription fulfillment fees, and ancillary services. These public companies are grouped as trading comparables due to similar digital retail models, regulatory exposure, and scale-driven fulfillment economics, providing valuation benchmarks for digital pharmacy operators.

Typical capabilities include prescription processing and e-prescribing integrations, secure digital checkout, mail-order fulfillment with cold-chain where required, broad OTC catalogs, health supplements, beauty and personal care assortments, telemedicine consultations, auto-refill programs, and marketplace merchandising for third-party brands. Companies emphasize omnichannel customer acquisition, data-driven pricing and promotions, pharmacy compliance workflows, and scalable last-mile logistics to support high-volume repeat orders and efficient basket consolidation.

Primary customers are individual consumers and patients, including chronic care populations, with secondary relationships to healthcare providers and payers through prescription processing. Valuation drivers include active customer growth, repeat prescription rates, average order value and category mix, gross margin and contribution margin, and fulfillment efficiency. Investors compare revenue growth trajectories, customer acquisition costs versus lifetime value, and EBITDA margin expansion across public trading comparables.

2. Valuation Analysis: Public Trading Comps & Multiples for Online Pharmacy and Telehealth Companies companies

2.1 - Public Peer Groups & Median Valuation Multiples for Online Pharmacy and Telehealth Companies sector

Description: Companies in this group operate online pharmacy platforms that dispense prescription and OTC medications via mail‑order logistics, complemented by health and personal care marketplaces and, in some cases, telemedicine. They monetize through e-commerce product sales, prescription fulfillment fees, and ancillary services. These public companies are grouped as trading comparables due to similar digital retail models, regulatory exposure, and scale-driven fulfillment economics, providing valuation benchmarks for digital pharmacy operators.
Redcare Pharmacy logo

Redcare Pharmacy

Website β€’ HQ: Netherlands
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of online pharmaceutical retail services, offering a wide range of prescription and non-prescription medications, beauty and personal care products, and health supplements to customers in Europe.
  • Key Products:
  • Prescription Medications: Online order and delivery of prescription drugs
  • Over-the-Counter Medications: Non-prescription pharmaceuticals available for online purchase
  • Beauty and Personal Care: Wide range of beauty and personal care products
  • Health Supplements: Various health supplements and vitamins
  • E-prescription Services: Digital platform for managing and redeeming e-prescriptions
Zur Rose Group logo

Zur Rose Group

Website β€’ HQ: Switzerland
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of pharmaceutical distribution solutions focusing on wholesale trade of medicines and operation of a mail-order pharmacy, offering a broad range of e-commerce and professional health services through digital platforms.
  • Key Products:
  • E-commerce Pharmacy: Online platform for ordering prescription and over-the-counter medications
  • Mail-order Pharmacy: Delivery service for prescription drugs and health products
  • Marketplace: Digital marketplace for health, beauty, and personal care products
  • Telemedicine: Online consultation services with healthcare professionals
  • Digital Health Services: AI-supported applications for drug management and health monitoring.
πŸ”’
πŸ”’
πŸ”’
πŸ”’
πŸ”’
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

2.3 - Precedent M&A Transactions & Implied Enterprise Values for the Online Pharmacy and Telehealth Companies secto

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

3. Potential Strategic Acquirers for Online Pharmacy and Telehealth Companies

3.1 Top Strategic Buyers in Online Pharmacy and Telehealth Companies

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

3.2 - Strategic Buyer Groups & Adjacent Industry and Verticals to the Online Pharmacy and Telehealth Companies sector

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

4. Financial Sponsors & Private Equity in Online Pharmacy and Telehealth Companies

4.1 - Buyout Funds active in Online Pharmacy and Telehealth Companies

Buyout Funds investing in Online Pharmacy and Telehealth Companies companies

50+ funds
Description: Buyout funds focused on Online Pharmacy and Telehealth Companies companies globally.

4.2 - 4.2 - Growth Capital & Late-Stage Investorsin Online Pharmacy and Telehealth Companies sector

Growth Equity Funds in Online Pharmacy and Telehealth Companies companies

40+ funds
Description: Growth equity funds focused on Online Pharmacy and Telehealth Companies companies globally.
πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

Valuation FAQ: Online Pharmacy and Telehealth Companies

What is the current median EV/Revenue multiple for Online Pharmacy and Telehealth Companies?

Based on our index of public trading comparables, the median Enterprise Value to Revenue (EV/Rev) multiple for the Online Pharmacy and Telehealth Companies sector is currently ●.●x. High-growth peers in the top quartile are trading at ●●.●x. View full data.

What is the average EV/EBITDA multiple for companies in this sector?

Profitable companies in the Online Pharmacy and Telehealth Companies sector trade at a median EV/EBITDA multiple of ●●.●x. This represents a change vs the 5-year historical average. Our platform tracks EBITDA multiples for Online Pharmacy and Telehealth Companies and other key peer groups.

How have valuation multiples for Online Pharmacy and Telehealth Companies trended over the last 5 years?

Valuations have adjusted since 2021. The sector saw peak multiples of ●●.●x EV/Revenue, settling to a 5-year average of ●.●x today. Access our Historical Trends chart for granular monthly data.

What are recent M&A transaction multiples in the Online Pharmacy and Telehealth Companies space?

Recent precedent transactions indicate implied enterprise values ranging from ●.●x to ●●.●x Revenue. Private market deals often trade at a liquidity discount compared to public peers. Unlock the full list of precedent transactions.

Which public companies are used as trading comps for Online Pharmacy and Telehealth Companies?

The primary trading comparable group includes Online Pharmacy and Telehealth Companies. Key constituents used for benchmarking include large-cap leaders and specialized mid-cap players. See the full list of companies in the Public Trading Comps section.

How do I value a private company in the Online Pharmacy and Telehealth Companies sector?

Valuing a private Online Pharmacy and Telehealth Companies company typically involves applying current EV/Revenue and EV/EBITDA multiples from public peers to the private company's financial metrics. A discount for lack of marketability (DLOM) of 20-30% is often applied. Our private company valuation database provides the exact multiples needed for this calculation.

What are the Online Pharmacy and Telehealth Companies industry valuation multiples for 2025?

For 2025, the Online Pharmacy and Telehealth Companies industry is trading at a median EV/Revenue multiple of ●.●x. This reflects current market sentiment, interest rates, and growth expectations. Access our platform to see how these multiples have changed from 2024 to 2025.

What is the difference between trading comps and transaction multiples for Online Pharmacy and Telehealth Companies?

Trading comps look at how public markets value similar companies today, while transaction multiples (or precedent transactions) look at the price paid in past M&A deals. Transaction multiples often include a "control premium," typically resulting in higher valuations than trading comps. Our database tracks both trading multiples and M&A transaction multiples.

Ready to Find Valuation benchmarks?

Access complete buyer lists, valuation data, and M&A intelligence for Online Pharmacy and Telehealth Companies

Launch login modal Launch register modal